Skip to content

Farmalys

Active
Private limited companyfounded 2025active for 1 yearAndrée Dumontgaarde 2, 1180 Ukkel, BelgiumKBO/BCE: BE 1029.355.486
Summary

Farmalys has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €17,462 and a net result of €15,295. Its solvency ranks better than 41% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-10-2025 Normal situation
Activity
Other human health activities NACE 86999and 5 others
Establishment unit
2.380.426.421 1180 Ukkel, since 20-10-2025
Financial year end
31 December
Peppol
Reachable since 07-12-2025

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€21,332
Turnover
≈ €130,000
estimated
Profit
€15,295
Equity
€17,462
Total assets
€33,513
  • 2025 accounts filed 23 days after the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.09, cash €22,798Figures for financial year 2025 (filed on 23-08-2026)Equity €17,462 (52.1% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 60% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 77
equity 52.1% of total assets
Liquidity 76
short-term debt 47.9% · cash 68.0%
Profitability 100
return on assets 45.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.09, above the usual 1.5. Short-term debt is 47.9% and cash 68% of total assets. 47.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 42% of them on solvency, 58% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.09, cash €22,798
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 23-08-2026)
NBB · annual accounts
lowers risk · Equity €17,462 (52.1% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
raises risk · 2025 accounts filed 23 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-08-2026, 23 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
23 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Less equity than 83% of companies in human healthsector median €124,659 · 20,702 companies €17,462 View

Recent changes

  1. · Gazette deed IncorporationStarting capital €3,000 · Appointment: BEAUPORT Aliette Mathilde Rebecca Virginie Hélèna (director)
All 2 events

Comparable companies

These companies have the same main activity as Farmalys: other human health activities (NACE 86999). They are comparable in size and age: total assets between €22,500 and €68,300, founded between 2024 and 2025.

CompanyTotal assetsGross margin
Farmalys Ukkel€33,513€21,332
Yoroshe Koekelberg€40,300€27,882
CARE POUR TOUS Sint-Agatha-Berchem€35,315€40,930
Delsipée Véronique Jurbise€49,023€17,153
PodoMouv Villers-la-Ville€22,468€21,791
DOKTER ALICE SPINOY Kortrijk€40,191€37,490
Personal Coach 4U Wommelgem€68,334€19,375
Full comparison

Key facts about Farmalys

What is the company number of Farmalys?
The company number of Farmalys is 1029.355.486. The VAT number is the same number with BE in front: BE 1029.355.486.
Where is Farmalys based?
The registered office is at Andrée Dumontgaarde 2, 1180 Ukkel.Company details
What does Farmalys do?
According to the KBO register, the main activity is other human health activities (NACE 86999).
What is the legal form of Farmalys?
The legal form of Farmalys is Private limited company (BV).
When was Farmalys founded?
Farmalys was founded on 20-10-2025.
Is Farmalys still active?
Yes, Farmalys is an active enterprise in the KBO register.
What is the turnover of Farmalys?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €21,332 and 41 comparable companies (NACE 869). It probably lies between €86,000 and €220,000. It is a rough estimate.Financials
Is Farmalys profitable?
In financial year 2025, Farmalys made a profit of €15,295.
Where can I find the annual accounts of Farmalys?
Farmalys filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.